CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,580,801 | -28.2% | 3,048,257 | -48.4% | 5.18% | -20.7% |
| Q4 2022 | $37,026,858 | +79.1% | 5,905,400 | 0.0% | 6.54% | +5.4% |
| Q3 2022 | $20,669,000 | +18.6% | 5,905,400 | 0.0% | 6.20% | -16.2% |
| Q2 2022 | $17,421,000 | -5.1% | 5,905,400 | 0.0% | 7.40% | +0.4% |
| Q1 2022 | $18,366,000 | -8.0% | 5,905,400 | 0.0% | 7.37% | -21.1% |
| Q4 2021 | $19,960,000 | – | 5,905,400 | – | 9.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |